AstraZeneca targets Rhythm with $10bn offer
AstraZeneca reportedly made a $10 billion offer for Rhythm Pharmaceuticals, sending shares up 28% and targeting the obesity and rare disease markets.
31 min ago13 min read
AstraZeneca reportedly made a $10 billion offer for Rhythm Pharmaceuticals, sending shares up 28% and targeting the obesity and rare disease markets.